Rawmax Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2015.
2015 Nagpur, Maharashtra, India Struck Off
Last Updated:
Access Report
About Rawmax Pharmaceutical Private Limited

Rawmax Pharmaceutical Private Limited, a struck off private limited company, was established on 19 May 2015 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2015PTC264624. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Umesh Kisanrao Wadekar (Director), Sanjay Bechan Chourasia (Director). Past directors included Shriram Manikarao Maslekar, Kamalkumar Nityanand Rawat, Amit Diware. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at H No 4485/193,Kashi Nagar, Rameshwari Road,, Nagpur, Maharashtra, 440027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51101MH2015PTC264624

  • Registration Number

    264624

  • Incorporation Date

    19 May 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 10 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth **** 29.43%
  • Profit Growth **** 87.08%
  • Ebitda **** 97.96%
  • Net Worth -13.17%
  • Total Assets **** 4.06%
Company report

Rawmax Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rawmax Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rawmax Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Umesh Kisanrao Wadekar Director 19 May 2015 Current
Sanjay Bechan Chourasia Director 07 Oct 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Jun 2015 Past
Pramod Abcsdd Director 01 Feb 2022 Past
Pramod Abcsdd Director 07 Oct 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rawmax Pharmaceutical.

Rawmax Pharmaceutical Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 29.43% increase. The company also saw a substantial improvement in profitability, with a 87.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.17%.

Rawmax Pharmaceutical revenue growth over time
Rawmax Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 29.43%
*******
*******
*******
*******
Revenue from Operations
*******
 29.39%
*******
*******
*******
*******
Total Assets
*******
 4.06%
*******
*******
*******
*******
Profit or Loss
*******
 87.08%
*******
*******
*******
*******
Net Worth
*******
 -13.17%
*******
*******
*******
*******
EBITDA
*******
 97.96%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rawmax Pharmaceutical?

In 2017, Rawmax Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rawmax Pharmaceutical?

Unlock and access historical data on people associated with Rawmax Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rawmax Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rawmax Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rawmax Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rawmax Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Rawmax Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was completed.

  • Director Appointment

    Sanjay Bechan Chourasia was appointed as a Director was appointed as a Director on 07 Oct 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Umesh Kisanrao Wadekar was appointed as a Director was appointed as a Director on 19 May 2015 & has been associated with this company since 10 years 10 months . was completed.

  • Company Incorporation

    Progress on Rawmax Pharmaceutical Private Limited was registered on 19 May 2015 with Roc Mumbai & aged 10 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rawmax Pharmaceutical Private Limited?

The CIN of Rawmax Pharmaceutical Private Limited is U51101MH2015PTC264624.

Where is Rawmax Pharmaceutical Private Limited headquartered?

Rawmax Pharmaceutical Private Limited is headquartered at H No 4485/193,Kashi Nagar, Rameshwari Road,, Nagpur, Maharashtra, 440027.

When was Rawmax Pharmaceutical Private Limited incorporated?

Rawmax Pharmaceutical Private Limited was incorporated on 19 May 2015.

Who are the current directors of Rawmax Pharmaceutical Private Limited?

The current directors of Rawmax Pharmaceutical Private Limited are

What is the primary industry of Rawmax Pharmaceutical Private Limited?

The primary industry of Rawmax Pharmaceutical Private Limited is Trade.

Is Rawmax Pharmaceutical Private Limited a listed company?

Rawmax Pharmaceutical Private Limited is unlisted.

What is the capital structure of Rawmax Pharmaceutical Private Limited?

The authorized capital of Rawmax Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rawmax Pharmaceutical Private Limited?

The compliance status of Rawmax Pharmaceutical Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available